English | Español

Biospace
+ Pharmaceuticals
Patient Daily | Jan 28, 2026

Advanced Therapies Week addresses scientific gains amid regulatory challenges
+ Pharmaceuticals
Patient Daily | Jan 28, 2026

BioSpace releases 2026 employment outlook report based on survey of 1,600 respondents
+ Pharmaceuticals
Patient Daily | Jan 27, 2026

Boehringer Ingelheim signs $1.26B deal with Simcere for IBD drug candidate
+ Pharmaceuticals
Patient Daily | Jan 27, 2026

Pharma firms agree to supply US stockpile but keep key details private
+ Pharmaceuticals
Patient Daily | Jan 27, 2026

Rare disease drug developers outline strategies at J.P. Morgan Healthcare conference
+ Pharmaceuticals
Patient Daily | Jan 27, 2026

Pharmaceutical companies announce new investments creating hundreds of U.S. manufacturing jobs
+ Pharmaceuticals
Patient Daily | Jan 27, 2026

Venture capitalists emphasize founder background as biotech funding tightens
+ Pharmaceuticals
Patient Daily | Jan 27, 2026

Strive Compounding Pharmacy sues Eli Lilly and Novo Nordisk over alleged antitrust practices

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation